Table 1 Detailed patient characteristics of the 62 HIV-positive patients
62 HIV positive patients | 66 Bronchoalveolar lavage | Statistical significance | |
|---|---|---|---|
Characteristics | Group 1: IF positive | Group 2: IF negative | |
Subjects | 30 | 36 | |
Age years (median, IQR) | 41 (34.5–50.5) | 41.5 (33.7–48) | ns |
Male/female | 21/9 | 23/13 | ns |
HIV background | |||
CD4 + counts/ml (median, IQR) | 39 (11.5– 65) | 104.5 (22.7–190) | s |
Viral load copies/ml (median, IQR) | 189,058 (84,818.7–671,206.5) | 180,009 (43,062.5–745,879.2) | ns |
cART (%) | 3 (10%) | 26 (72.2%) | s |
Symptoms between hospitalisation and BAL | |||
Fever | 19 (63.3) | 22 (61.1) | ns |
Cough | 25 (83.3) | 32 (88.8) | ns |
Dyspnea | 20 (66.6) | 15 (41.6) | ns |
Laboratory analysis | |||
LDH (U/l) | 588.5 (506.7–854.5) | 463.5 (384.2–542.5) | s |
Outcome | |||
In hospital death | 1 (3.3) | 2 (5.5) | ns |
Therapy/prophylaxis | |||
PCP-Prophylaxis before BAL | 2 (6.6) | 13 (36.1) | s |
PCP-Therapy after BAL | 30 (100) | 14 (38.8) | s |
PCR Pneumocystis results | |||
Amount of positive qualitative PCR results | 30 (100) | 1 (2.7) | s |
Positive quantitative PCR copies/ml (median, IQR) | 506,068.59 (141,239.7–783,667.2) | 298 | s |